ENDRA Life Sciences NDRA Stock
ENDRA Life Sciences Price Chart
ENDRA Life Sciences NDRA Financial and Trading Overview
| ENDRA Life Sciences stock price | 4.69 USD |
| Previous Close | 1.47 USD |
| Open | 1.49 USD |
| Bid | 0 USD x 1200 |
| Ask | 0 USD x 1000 |
| Day's Range | 1.42 - 1.57 USD |
| 52 Week Range | 1.02 - 7.6 USD |
| Volume | 64.58K USD |
| Avg. Volume | 47.63K USD |
| Market Cap | 11M USD |
| Beta (5Y Monthly) | 0.82183 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -56.94 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20 USD |
NDRA Valuation Measures
| Enterprise Value | 9.24M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.96710527 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.0352113 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.703 |
Trading Information
ENDRA Life Sciences Stock Price History
| Beta (5Y Monthly) | 0.82183 |
| 52-Week Change | -65.49% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.6 USD |
| 52 Week Low | 1.02 USD |
| 50-Day Moving Average | 1.61 USD |
| 200-Day Moving Average | 3.86 USD |
NDRA Share Statistics
| Avg. Volume (3 month) | 47.63K USD |
| Avg. Daily Volume (10-Days) | 57.92K USD |
| Shares Outstanding | 7.48M |
| Float | 7.13M |
| Short Ratio | 1 |
| % Held by Insiders | 7.87% |
| % Held by Institutions | 5.73% |
| Shares Short | 53.21K |
| Short % of Float | 0.72% |
| Short % of Shares Outstanding | 0.70% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -94.091% |
| Return on Equity (ttm) | -195.51% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -13129479 USD |
| Net Income Avi to Common (ttm) | -13263636 USD |
| Diluted EPS (ttm) | -4 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.36M USD |
| Total Cash Per Share (mrq) | 0.32 USD |
| Total Debt (mrq) | 593.85K USD |
| Total Debt/Equity (mrq) | 13.2 USD |
| Current Ratio (mrq) | 3.013 |
| Book Value Per Share (mrq) | 1.42 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12177348 USD |
| Levered Free Cash Flow (ttm) | -6816348 USD |
Profile of ENDRA Life Sciences
| Country | United States |
| State | MI |
| City | Ann Arbor |
| Address | 3600 Green Court |
| ZIP | 48105-1570 |
| Phone | 734 335 0468 |
| Website | https://www.endrainc.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 21 |
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Q&A For ENDRA Life Sciences Stock
What is a current NDRA stock price?
ENDRA Life Sciences NDRA stock price today per share is 4.69 USD.
How to purchase ENDRA Life Sciences stock?
You can buy NDRA shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ENDRA Life Sciences?
The stock symbol or ticker of ENDRA Life Sciences is NDRA.
Which industry does the ENDRA Life Sciences company belong to?
The ENDRA Life Sciences industry is Diagnostics & Research.
How many shares does ENDRA Life Sciences have in circulation?
The max supply of ENDRA Life Sciences shares is 562.21K.
What is ENDRA Life Sciences Price to Earnings Ratio (PE Ratio)?
ENDRA Life Sciences PE Ratio is now.
What was ENDRA Life Sciences earnings per share over the trailing 12 months (TTM)?
ENDRA Life Sciences EPS is -56.94 USD over the trailing 12 months.
Which sector does the ENDRA Life Sciences company belong to?
The ENDRA Life Sciences sector is Healthcare.
ENDRA Life Sciences NDRA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16113.14 USD — |
+3.27
|
1.58B USD — | 16080.5 USD — | 16202.1 USD — | — - | 1.58B USD — |
| NASDAQ HealthCare IXHC | 884.5 USD — |
+2.19
|
— — | 880.54 USD — | 886.78 USD — | — - | — — |
| NASDAQ Capital Market Composite RCMP | 94.3 USD — |
+2.59
|
— — | 94.18 USD — | 95.07 USD — | — - | — — |
- {{ link.label }} {{link}}